Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01142908 · ClinicalTrials.gov registry record · NA

Cardiovascular Intervention Improvement Telemedicine Study

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
428
Enrollment target

NCT01142908: Completed NA study, sponsored by VA Office of Research and Development.

NCT01142908 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 428 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01142908, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
428 participants
Enrollment target

Study Summary

Cardiovascular disease (CVD) is the leading cause of death in the United States; more than 80% of veterans have \> 2 risk factors for CVD. Our study is one of the first to examine the implementation of a tailored behavioral/educational self-management intervention in primary care clinics designed to improve CVD risk. The proposed study could result in a leap forward in CVD risk management among veterans for several reasons: 1) ) This is a novel extension of our previous interventions that have demonstrated improved BP, now designed to address multiple chronic conditions contributing to CVD risk, particularly hyperlipidemia and diabetes. The study focuses on both multiple CVD-related risk factor management and medication management 2) The intervention is multi-behavioral; it addresses patients' various health behavior (e.g., smoking, diet, and medication adherence). 3) Components of the intervention will include specific recommendations and transportability of intervention application software and tracking packages that will allow clinic managers to implement the intervention if it is effective.

Interventions

  • BEHAVIORAL Pharmacist CVD

Trial Details

FieldValue
Enrollment Target 428 participants
Start Date 2011-11-01
Est. Completion 2015-05-22
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT01142908

The ClinicalTrials.gov registry entry for NCT01142908 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 428 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Pharmacist CVD is the first listed.

NCT01142908 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01142908 about?

NCT01142908 is a clinical study titled "Cardiovascular Intervention Improvement Telemedicine Study". Cardiovascular disease (CVD) is the leading cause of death in the United States; more than 80% of veterans have \> 2 risk factors for CVD. Our study is one of the first to examine the implementation of a tailored behavioral/educational self-management intervention in primary care clinics designed to...

What is the current status of trial NCT01142908?

This trial is currently completed. It is a NA study. The enrollment target is 428 participants. The study started on 2011-11-01. Estimated completion is 2015-05-22.

What interventions are being tested in trial NCT01142908?

The interventions under investigation include: Pharmacist CVD (BEHAVIORAL).

Who is sponsoring clinical trial NCT01142908?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.